{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:55:42Z","timestamp":1792007742118,"version":"4.4.0"},"reference-count":46,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Breast cancer is a leading cause of cancer-related mortality, particularly in aggressive subtypes such as HER2-positive and triple-negative breast cancer (TNBC). Achieving a pathological complete response (pCR) after neoadjuvant therapy is strongly associated with improved survival outcomes in these subgroups, making the prediction of pCR a clinical priority. Sarcopenia, a progressive loss of skeletal muscle mass and strength, is increasingly recognized in cancer patients and has been linked to chemotherapy toxicity and poorer survival. However, its specific impact on pCR in HER2-positive and TNBC patients remains unclear. This study aimed to evaluate the association between radiologically defined sarcopenia, or a low skeletal muscle index (SMI), and pathological response in these subtypes, and to explore its potential as a predictive biomarker. Materials and Methods: This retrospective study included patients with HER2-positive or TNBC who received neoadjuvant therapy between January 2015 and October 2023. SMI was assessed using pre-treatment positron emission tomography images at the L3 vertebral level, with values &lt; 38.5 cm2\/m2 considered as low. Univariate and multivariate logistic regression analyses were performed to identify factors associated with pCR. Results: A total of 85 patients were included, with low SMI present in 35 (41.2%). In univariate analysis, clinical stage and low SMI were associated with pCR. However, in the multivariate model, only low SMI remained an independent predictor. Patients without low SMI had higher odds of achieving pCR (odds ratio [OR] 4.13; 95% confidence interval [CI] 1.55\u201310.95; p = 0.004). Low SMI was also associated with higher rates of treatment-related toxicity (42.9% vs. 20.0%, p = 0.023). Conclusions: Pre-treatment low SMI is strongly associated with lower pCR rates in patients with HER2-positive and TNBC undergoing neoadjuvant therapy. These findings underscore the importance of early identification and management of radiologically defined sarcopenia to optimize treatment response and improve clinical outcomes.<\/jats:p>","DOI":"10.3390\/medicina61091508","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T11:50:31Z","timestamp":1755863431000},"page":"1508","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Low Skeletal Muscle Index as a Predictor of Pathological Complete Response in HER-2 Positive and Triple-Negative Breast Cancer"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-3936","authenticated-orcid":false,"given":"Murat","family":"G\u00fcnalt\u0131l\u0131","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2981-8098","authenticated-orcid":false,"given":"Murad","family":"Guliyev","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8199-4153","authenticated-orcid":false,"given":"Mehmet Cem","family":"Fidan","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliha","family":"Birsin","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emir","family":"\u00c7erme","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-9348","authenticated-orcid":false,"given":"Vali","family":"Aliyev","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Abbasov","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Cebeci","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-1712","authenticated-orcid":false,"given":"Seda","family":"Jeral","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-2012","authenticated-orcid":false,"given":"\u00d6zkan","family":"Alan","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebi Serkan","family":"Demirci","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7i\u011fdem","family":"Papila","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur Erdem","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said Erkam","family":"B\u0131y\u0131ko\u011flu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fclin","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berrin","family":"Papila","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: A pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10549-018-4801-3","article-title":"Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy","volume":"170","author":"Haque","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: A comprehensive meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Guliyev, M., Alan, \u00d6., G\u00fcnalt\u0131l\u0131, M., Safarov, S., Fidan, M.C., \u015een, G.A., De\u011ferli, E., Papila, B., Demirci, N.S., and Papila, \u00c7. (2024). Obesity is an independent prognostic factor that reduced pathological complete response in operable breast cancer patients. Medicina, 60.","DOI":"10.3390\/medicina60121953"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Cesari, M., Landi, F., Vellas, B., Bernabei, R., and Marzetti, E. (2014). Sarcopenia and physical frailty: Two sides of the same coin. Front. Aging Neurosci., 6.","DOI":"10.3389\/fnagi.2014.00192"},{"key":"ref_10","first-page":"305","article-title":"Dual-energy X-ray absorptiometry and body composition","volume":"8","author":"Plank","year":"2005","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/ajcn\/86.4.952","article-title":"Estimation of thigh muscle cross-sectional area by dual-energy X-ray absorptiometry in frail elderly patients","volume":"86","author":"Hansen","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Albano, D., Pasinetti, N., Dondi, F., Giubbini, R., Tucci, A., and Bertagna, F. (2022). Prognostic role of pre-treatment metabolic parameters and sarcopenia derived by 2-[18F]-FDG PET\/CT in elderly mantle cell lymphoma. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051210"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"20200672","DOI":"10.1259\/bjr.20200672","article-title":"Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of 18F-FDG PET\/CT in elderly Hodgkin lymphoma patients: A two-centre validation","volume":"94","author":"Albano","year":"2021","journal-title":"Br. J. Radiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11604-022-01369-9","article-title":"Role of 18F-FDG PET\/CT and sarcopenia in untreated non-small cell lung cancer with advanced stage","volume":"41","author":"Yuan","year":"2023","journal-title":"Jpn. J. Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zwart, A.T., Kok, L.M.C., de Vries, J., van Kester, M.S., Dierckx, R.A.J.O., de Bock, G.H., van der Hoorn, A., and Halmos, G.B. (2023). Radiologically Defined Sarcopenia as a Biomarker for Frailty and Malnutrition in Head and Neck Skin Cancer Patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12103445"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.21873\/anticanres.15051","article-title":"Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival","volume":"41","author":"Orsaria","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/ERC-18-0029","article-title":"Impact of hormone receptor status on the efficacy of HER2-targeted treatment","volume":"25","author":"Zhao","year":"2018","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: Findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann. Surg."},{"key":"ref_20","first-page":"6862","article-title":"Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy","volume":"7","author":"Tan","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-018-4797-8","article-title":"BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients","volume":"171","author":"Wunderle","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","article-title":"Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bellieni, A., Fusco, D., Sanchez, A.M., Franceschini, G., Di Capua, B., Allocca, E., Di Stasio, E., Marazzi, F., Tagliaferri, L., and Masetti, R. (2021). Different impact of definitions of sarcopenia in defining frailty status in a population of older women with early breast cancer. J. Pers. Med., 11.","DOI":"10.3390\/jpm11040243"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1634\/theoncologist.2019-0751","article-title":"Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy","volume":"25","author":"Bilen","year":"2020","journal-title":"Oncologist"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1634\/theoncologist.2012-0169","article-title":"The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer","volume":"17","author":"Parsons","year":"2012","journal-title":"Oncologist"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","article-title":"A new histological grading system to assess response of breast cancers to primary chemotherapy: Prognostic significance and survival","volume":"12","author":"Ogston","year":"2003","journal-title":"Breast"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3350\/cmh.2017.0077","article-title":"Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis","volume":"24","author":"Gu","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13244-015-0414-0","article-title":"Imaging body composition in cancer patients: Visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome","volume":"6","author":"Yip","year":"2015","journal-title":"Insights Imaging"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bursac, Z., Gauss, C.H., Williams, D.K., and Hosmer, D.W. (2008). Purposeful selection of variables in logistic regression. Source Code Biol. Med., 3.","DOI":"10.1186\/1751-0473-3-17"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jand.2020.03.021","article-title":"The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review","volume":"120","author":"Findlay","year":"2020","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Roberto, M., Barchiesi, G., Resuli, B., Verrico, M., Speranza, I., Cristofani, L., Pediconi, F., Tomao, F., Botticelli, A., and Santini, D. (2024). Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16030596"},{"key":"ref_34","first-page":"316","article-title":"Exploring the impact of sarcopenia on mortality in breast cancer patients: A comprehensive systematic review and meta-analysis","volume":"19","author":"Dai","year":"2024","journal-title":"Breast Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"AB020","DOI":"10.21037\/map.2019.AB020","article-title":"Prevalence of sarcopenia and its impact on survival in breast cancer\u2014A systematic review and meta-analysis","volume":"3","author":"Simmons","year":"2019","journal-title":"Mesentery Peritoneum"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e945240","DOI":"10.12659\/MSM.945240","article-title":"Sarcopenia\u2019s Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis","volume":"30","author":"Karaca","year":"2024","journal-title":"Med. Sci. Monit."},{"key":"ref_37","first-page":"137","article-title":"Sarcopenia in patients with normal body mass index is an independent predictor for postoperative complication and long-term survival in gastric cancer","volume":"14","author":"Sun","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.2147\/IJGM.S497897","article-title":"Sarcopenia as a prognostic factor and multimodal interventions in breast cancer","volume":"17","author":"Du","year":"2024","journal-title":"Int. J. Gen. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhang, X., Dou, Q., Zeng, Y., Yang, Y., Cheng, A., and Zhang, W. (2020). Sarcopenia as a predictor of mortality in women with breast cancer: A meta-analysis and systematic review. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-6645-6"},{"key":"ref_40","first-page":"e61145","article-title":"The Relationship Between Body Composition and Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients","volume":"16","author":"Yilmaz","year":"2024","journal-title":"Cureus"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Guo, J., Meng, W., Li, Q., Zheng, Y., Yin, H., Liu, Y., Zhao, S., and Ma, J. (2024). Pretreatment sarcopenia and MRI-based radiomics to predict the response of neoadjuvant chemotherapy in triple-negative breast cancer. Bioengineering, 11.","DOI":"10.3390\/bioengineering11070663"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"111704","DOI":"10.1016\/j.nut.2022.111704","article-title":"Prevalence and prognostic value of sarcopenic obesity in patients with cancer: A systematic review and meta-analysis","volume":"101","author":"Gao","year":"2022","journal-title":"Nutrition"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10549-019-05352-3","article-title":"Muscle composition and outcomes in patients with breast cancer: Meta-analysis and systematic review","volume":"177","author":"Aleixo","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_44","first-page":"328","article-title":"Prevalence and clinical implications of sarcopenia in breast cancer: A systematic review and meta-analysis","volume":"32","author":"Jang","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Matuszczak, M., Kilja\u0144czyk, A., Marciniak, W., Derkacz, R., Stempa, K., Baszuk, P., Bry\u015bkiewicz, M., Cybulski, C., D\u0119bniak, T., and Gronwald, J. (2024). Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers. Antioxidants, 13.","DOI":"10.3390\/antiox13070841"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.breast.2021.12.014","article-title":"Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?","volume":"61","author":"Deluche","year":"2022","journal-title":"Breast"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1508\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:44Z","timestamp":1760034824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091508"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091508","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}